Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A1 | P43005 | 2/20 | 0.55 |
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | LTA4H | P09960 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | GRM8 | O00222 | 1/20 | 0.37 |
| ▸ | GRM6 | O15303 | 1/20 | 0.37 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.37 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.37 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | GRM5 | P41594 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL131049 | 1.00 | SLC1A1 (0.55) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| SCHEMBL1318285 | 1.00 | SLC1A1 (0.55) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| Hydrochloric Acid SCHEMBL1238805 | 0.98 | SLC1A1 (0.53) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| Hydrochloric Acid SCHEMBL624145 | 0.98 | SLC1A1 (0.53) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| Hydrochloric Acid SCHEMBL624146 | 0.98 | SLC1A1 (0.53) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| SCHEMBL20474981 | 0.91 | SLC1A1 (0.47) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| SCHEMBL10633361 | 0.91 | SLC1A1 (0.47) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| SCHEMBL10141318 | 0.88 | TSHR (0.54) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| SCHEMBL3417164 | 0.88 | TSHR (0.54) | SLC1A1TSHRLTA4HLMNAKDM4E | |
| SCHEMBL2723398 | 0.88 | SLC1A1 (0.51) | SLC1A1TSHRLTA4HLMNAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1767 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522747-B2 | Coating compositions for use in creped paper product manufacturing and methods for producing the same | SOLENIS TECHNOLOGIES, L.P. (US) | 2026-01-13 | — | — | US | claimed |
| US-20250289842-A1 | Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates | AMGEN INC. | 2025-09-18 | — | — | US | claimed |
| CN-120136760-A | Industrial production method of key intermediate of Nemactevir | 沧州那瑞化学科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| EP-4519278-A1 | PROCESSES FOR MAKING NAG-25, A CARBOHYDRATE TARGETING MOIETY, AND ITS INTERMEDIATES | Amgen Inc. (US) | 2025-03-12 | — | — | EP | claimed |
| CN-119562958-A | Methods for preparing NAG-25 carbohydrate targeting moieties and intermediates thereof | 安进公司 | 2025-03-04 | — | — | CN | claimed |
| CN-119409588-A | Caffeoyl amino acid methyl ester derivative and preparation method and application thereof | 西北大学 | 2025-02-11 | — | — | CN | claimed |
| CN-119351754-A | Recycling treatment method of copper-containing sludge | 江西省金瑞环保科技有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-119241617-A | 2 '-Deoxy-2' -fluoro-N4-substituted cytidine compound, preparation method and application thereof | 河南省科学院高新技术研究中心 | 2025-01-03 | — | — | CN | claimed |
| CN-119161331-A | Preparation method of degradation impurities in raltitrexed preparation | 浙江皓格药业有限公司 | 2024-12-20 | — | — | CN | claimed |
| US-20240398552-A1 | Scaffold For Nasal Tissue Engineering | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2024-12-05 | — | — | US | claimed |
| US-5567610-A | EXPOSING HUMAN LYMPHOCYTES TO A LYSOMOTROPHIC AGENT MONOPEPTIDE METHYL ESTER OR DIPEPTIDE METHYL ESTER | BIOINVENT INTERNATIONAL AB (SE) | 1996-10-22 | — | — | US | claimed |
| EP-0701446-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1996-03-20 | — | — | EP | claimed |
| EP-0644887-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID. | SMITHKLINE BEECHAM PLC (GB) | 1995-03-29 | — | — | EP | claimed |
| WO-1994027627-A1 | HEMOREGULATORY PEPTIDES | SMITHKLINE BEECHAM CORPORATION (US) | 1994-12-08 | — | — | WO | claimed |
| CN-1095069-A | Novel process for the preparation and/or purification of clavulanic acid or pharmaceutically acceptable salts or esters thereof | SMITHKLINE BEECHAM PLC (GB) | 1994-11-16 | — | — | CN | claimed |
| US-5300662-A | Process for producing coumarin and derivatives thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1994-04-05 | — | — | US | claimed |
| WO-1993025557-A1 | PROCESS FOR THE PREPARATION OF CLAVULANIC ACID | SMITHKLINE BEECHAM PLC (GB) | 1993-12-23 | — | — | WO | claimed |
| EP-0362031-B1 | COMPOUNDS ACTIVE AGAINST MALARIA OF THE TISSUES, AND PROCESS FOR THEIR PREPARATION | LA REGION WALLONNE (BE) | 1993-07-07 | — | — | EP | claimed |
| EP-0362031-A1 | Compounds active against malaria of the tissues, and process for their preparation | LA REGION WALLONNE (BE) | 1990-04-04 | — | — | EP | claimed |
| US-3936469-A | Process for preparing N-carboxylic anhydrides of amino acids | KYOWA HAKKO KOGYO KABUSHIKI KAISHA (JA) | 1976-02-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250289842-A1 | Processes for Making NAG-25, a Carbohydrate Targeting Moiety, and its Intermediates | ENGASE, MAN2B2, GALNT2 | SLC1A1 4275/4885TSHR 2215/4885LTA4H 3651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.